# XEGLYZE
> **NDA206966** · New Drug Application · Sponsor: LNHC · Approved 2020-07-24
## Drug
- **FDA Application Number:** NDA206966
- **Application type:** New Drug Application
- **Brand name:** XEGLYZE
- **Generic name:** Abametapir
- **Active ingredients:** ABAMETAPIR
- **Dosage form:** LOTION
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** LNHC
- **First approval:** 2020-07-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206966)
---
*MORVS · CC0 1.0*